Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1964 1
1967 2
1970 1
1981 1
1987 2
1988 1
1990 2
1992 8
1993 2
1994 4
1995 2
1996 1
1997 2
1998 4
1999 2
2000 1
2002 2
2003 3
2004 1
2005 1
2006 1
2007 2
2008 1
2009 2
2012 7
2013 2
2014 5
2015 2
2016 5
2017 10
2018 10
2019 3
2020 6
2021 11
2022 4
2023 3
2024 9
2025 15
2026 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

148 results

Results by year

Filters applied: . Clear all
Page 1
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen.
Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV. Stover CK, et al. Among authors: mizoguchi sd. Nature. 2000 Aug 31;406(6799):959-64. doi: 10.1038/35023079. Nature. 2000. PMID: 10984043
Microplastics in Human Bronchoalveolar Lavage Fluid.
Tokito T, Kido T, Nagafuchi O, Tomoshige K, Nakazawa K, Shinozuka K, Sato S, Kido K, Noguchi Y, Matsumoto T, Mizoguchi S, Murakami R, Yura H, Ishimoto H, Takazono T, Sakamoto N, Ishimatsu Y, Tanaka Y, Matsumoto K, Nagayasu T, Mukae H. Tokito T, et al. Among authors: mizoguchi s. Respirology. 2025 Dec;30(12):1141-1152. doi: 10.1111/resp.70107. Epub 2025 Aug 22. Respirology. 2025. PMID: 40843955 Free PMC article.
Comparison of real-world outcomes between nivolumab plus ipilimumab and lenvatinib plus pembrolizumab or nivolumab plus cabozantinib combination therapies for previously untreated advanced renal cell carcinoma.
Ishihara H, Omae K, Nemoto Y, Mizoguchi S, Katsurayama N, Nakayama T, Fukuda H, Yoshida K, Shimmura H, Hashimoto Y, Iizuka J, Kondo T, Takagi T. Ishihara H, et al. Among authors: mizoguchi s. Urol Oncol. 2025 Oct;43(10):598.e1-598.e10. doi: 10.1016/j.urolonc.2025.06.019. Epub 2025 Aug 5. Urol Oncol. 2025. PMID: 40754547
A Tunable Pulmonary Organoid Model Demonstrates Compositionally Driven Epithelial Plasticity and Immune Polarization.
Edelstein SE, Mizoguchi S, Gracia MT, Wang N, Lee V, Kim H, Haynes C, Danelski C, Tsuchiya T, Sauler M, Raredon MSB. Edelstein SE, et al. Among authors: mizoguchi s. bioRxiv [Preprint]. 2025 Jun 24:2025.06.05.658120. doi: 10.1101/2025.06.05.658120. bioRxiv. 2025. Update in: iScience. 2026 Feb 24;29(4):115030. doi: 10.1016/j.isci.2026.115030. PMID: 40501591 Free PMC article. Updated. Preprint.
Impact of starting dose of tyrosine kinase inhibitors on outcomes following combination therapy of immune checkpoint inhibitors with tyrosine kinase inhibitors for previously untreated advanced renal cell carcinoma.
Ishihara H, Nishimura K, Nemoto Y, Mizoguchi S, Nakayama T, Fukuda H, Shimmura H, Hashimoto Y, Yoshida K, Iizuka J, Kondo T, Takagi T. Ishihara H, et al. Among authors: mizoguchi s. Jpn J Clin Oncol. 2026 Jan 9;56(1):73-79. doi: 10.1093/jjco/hyaf152. Jpn J Clin Oncol. 2026. PMID: 41025729
Bio-3D printing with smooth muscle cells derived from human iPSCs via neural crest and its application for the tracheal regeneration.
Hashimoto S, Taniguchi D, Doi R, Obata T, Shiraishi T, Matsumoto T, Maruta H, Akao K, Mizoguchi S, Shimoyama K, Tominaga T, Miyazaki T, Nonaka T, Otsubo R, Takagi K, Iwatake M, Nakayama K, Ikeya M, Matsumoto K. Hashimoto S, et al. Among authors: mizoguchi s. Biofabrication. 2025 Nov 10;18(1). doi: 10.1088/1758-5090/ae1665. Biofabrication. 2025. PMID: 41125130
Effect of age on treatment outcomes of first-line immune checkpoint inhibitor combination therapy for previously untreated advanced renal cell carcinoma.
Ishihara H, Nishimura K, Nemoto Y, Mizoguchi S, Nakayama T, Fukuda H, Shimmura H, Hashimoto Y, Yoshida K, Iizuka J, Kondo T, Takagi T. Ishihara H, et al. Among authors: mizoguchi s. Geriatr Gerontol Int. 2025 Aug;25(8):1082-1088. doi: 10.1111/ggi.70105. Epub 2025 Jun 18. Geriatr Gerontol Int. 2025. PMID: 40534118
148 results